Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,8.195410074625084e-14,9.061691084685632,273.052467292557,"['RPL41', 'RPL23', 'RPS6', 'RPL13A', 'RPL23A', 'RPL10A', 'RPS15', 'RPS25', 'RPS17', 'RPS15A', 'RPS27', 'RPS6KA2', 'RPL27A', 'RPL37A', 'RPL36', 'RPL35', 'RPLP2', 'RPL24', 'RPL37', 'RPL26', 'RPL39', 'RPS13', 'RPS12', 'RPL19']",2.4586230223875254e-11,0,0,24
2,Calcium Regulation in the Cardiac Cell WP536,0.007214358097001185,2.5257936507936507,12.456411231240729,"['RGS5', 'PRKAR1B', 'GNG5', 'CACNA1B', 'GNAS', 'GNAI3', 'CACNA1A', 'ATP1B3', 'CACNA1D', 'ARRB2', 'ADCY8']",0.8571905693182404,0,0,11
3,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.010875617417698451,2.6515835942713415,11.98842441036409,"['SLC25A27', 'NDUFA7', 'NDUFB7', 'UQCRB', 'NDUFS3', 'NDUFA1', 'COX7C', 'ATP5MF', 'ATP5F1E']",0.8571905693182404,0,0,9
4,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.031334561824521705,2.7126129666011787,9.393869790125216,"['RAP1A', 'KCNIP3', 'RPS6', 'GNAI3', 'GNAS', 'JAK1']",0.8571905693182404,0,0,6
5,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.031334561824521705,2.7126129666011787,9.393869790125216,"['PRKN', 'PSMD6', 'GPR37', 'TUBB3', 'FBXW7', 'UBE2J2']",0.8571905693182404,0,0,6
6,Exercise-induced Circadian Regulation WP410,0.032141643481093725,3.052199258081611,10.492248669687285,"['PURA', 'BTG1', 'VAPA', 'TUBB3', 'ERC2']",0.8571905693182404,0,0,5
7,Zinc homeostasis WP3529,0.04499426108263369,4.22607421875,13.105987278381217,"['SLC39A9', 'SLC30A1', 'SLC39A12']",0.8571905693182404,0,0,3
8,Nuclear Receptors Meta-Pathway WP2882,0.04621593935948817,1.7554069436539557,5.396876704733773,"['CBR1', 'JUND', 'SLC6A16', 'ARNT', 'SLC39A12', 'SEC14L1', 'NAV3', 'SLC39A9', 'ACOX1', 'MFGE8', 'CPEB4', 'CAP2', 'FTL']",0.8571905693182404,0,0,13
9,Chemokine signaling pathway WP3929,0.057745553945086146,2.01025641025641,5.732666137636264,"['VAV3', 'RAP1A', 'GNG5', 'SHC1', 'PARD3', 'GNAI3', 'ARRB2', 'ADCY8']",0.8571905693182404,0,0,8
10,Oxidative phosphorylation WP623,0.06090692045670561,2.507843137254902,7.017969487567662,"['NDUFA7', 'NDUFB7', 'NDUFS3', 'ATP5MF', 'ATP5F1E']",0.8571905693182404,0,0,5
11,Aryl Hydrocarbon Receptor Pathway WP2873,0.06514262009053802,3.5578741776315788,9.717181481086705,"['JUND', 'ARNT', 'CAP2']",0.8571905693182404,0,0,3
12,Hedgehog Signaling Pathway WP4249,0.06576208740594557,2.818982387475538,7.672457588368793,"['BOC', 'FBXL17', 'GAS1', 'ARRB2']",0.8571905693182404,0,0,4
13,3q29 copy number variation syndrome WP4906,0.0745160586755841,2.3504901960784315,6.103613378781706,"['FBXW7', 'CEP19', 'CEP350', 'RNF8', 'RABL2B']",0.8571905693182404,0,0,5
14,Oncostatin M Signaling Pathway WP2374,0.0745160586755841,2.3504901960784315,6.103613378781706,"['JUND', 'SHC1', 'RPS6', 'RICTOR', 'JAK1']",0.8571905693182404,0,0,5
15,Ectoderm Differentiation WP2858,0.08302096237633387,1.844865756953669,4.591247570686771,"['TTC14', 'TFAP2C', 'STX16', 'BOC', 'UBTF', 'CTNNA2', 'ANKS1B', 'CAP2']",0.8571905693182404,0,0,8
16,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.08955343802088435,2.5048923679060664,6.04410428873735,"['MAPK10', 'RPS6KA2', 'RPS6', 'EIF4G3']",0.8571905693182404,0,0,4
17,Integrin-mediated Cell Adhesion WP185,0.10023212610444461,1.9624156487571538,4.5140790189163855,"['VAV3', 'MAPK10', 'RAP1A', 'SHC1', 'ARHGEF7', 'DOCK1']",0.8571905693182404,0,0,6
18,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.10390215710338266,4.091795144426723,9.265074740395125,"['SMAD2', 'CDH2']",0.8571905693182404,0,0,2
19,G Protein Signaling Pathways WP35,0.10514146982137162,1.9342127420712882,4.356714597352918,"['PRKAR1B', 'GNG5', 'GNAI3', 'GNAS', 'ADCY8', 'PDE8A']",0.8571905693182404,0,0,6
20,MAPK Signaling Pathway WP382,0.10698817170712328,1.5425628049882523,3.4476849369137565,"['MAPK10', 'CACNG7', 'PPM1B', 'JUND', 'RAP1A', 'DUSP1', 'CACNA1B', 'NF1', 'CACNA1A', 'CACNA1D', 'ARRB2', 'FGF22']",0.8571905693182404,0,0,12
21,Glucocorticoid Receptor Pathway WP2880,0.1097343837472373,2.311606202017161,5.107938948738939,"['SEC14L1', 'NAV3', 'MFGE8', 'CPEB4']",0.8571905693182404,0,0,4
22,Endoderm differentiation WP2853,0.1201844035664817,1.755511811023622,3.7194520622672043,"['SMAD2', 'VAV3', 'WDHD1', 'ATP8B2', 'WDFY2', 'NAA15', 'PIAS1']",0.8571905693182404,0,0,7
23,Interferon type I signaling pathways WP585,0.13174509056637443,2.145932345540956,4.349560991020849,"['RAP1A', 'RPS6', 'JAK1', 'PIAS1']",0.8571905693182404,0,0,4
24,Purinergic signaling WP4900,0.13238108420718897,3.4616884090568303,6.9997780613421305,"['GNAI3', 'GNAS']",0.8571905693182404,0,0,2
25,CAMKK2  Pathway WP4874,0.1344107217478197,2.501953125,5.021057336740404,"['MAF', 'NFATC2', 'ARHGEF7']",0.8571905693182404,0,0,3
26,Complement system WP2806,0.1344107217478197,2.501953125,5.021057336740404,"['GNAI3', 'CD59', 'ARRB2']",0.8571905693182404,0,0,3
27,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.1344107217478197,2.501953125,5.021057336740404,"['SMAD2', 'RICTOR', 'FBXO32']",0.8571905693182404,0,0,3
28,EGF/EGFR signaling pathway WP437,0.1398285668662171,1.5633019154758285,3.07554346560618,"['VAV3', 'RAP1A', 'JUND', 'SHC1', 'RPS6KA2', 'NCK2', 'GAB1', 'RICTOR', 'JAK1']",0.8571905693182404,0,0,9
29,Signaling of Hepatocyte Growth Factor Receptor WP313,0.14437562559939832,2.412388392857143,4.668784188331781,"['RAP1A', 'GAB1', 'DOCK1']",0.8571905693182404,0,0,3
30,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.14437562559939832,2.412388392857143,4.668784188331781,"['NFATC2', 'NELFA', 'HDAC9']",0.8571905693182404,0,0,3
31,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.14721214878396827,3.214146477304372,6.1579207001260565,"['RAP1A', 'GNAS']",0.8571905693182404,0,0,2
32,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.14734543361301186,2.048034157623199,3.9219353586100443,"['CACNG7', 'CDH2', 'CACNA1D', 'CTNNA2']",0.8571905693182404,0,0,4
33,IL-5 signaling pathway WP127,0.15457478362937785,2.3290005387931036,4.348423952231508,"['SHC1', 'RPS6', 'JAK1']",0.8571905693182404,0,0,3
34,Parkinson's disease pathway WP2371,0.15457478362937785,2.3290005387931036,4.348423952231508,"['PRKN', 'GPR37', 'UBE2J2']",0.8571905693182404,0,0,3
35,Mitochondrial complex I assembly model OXPHOS system WP4324,0.15540173405389873,2.002348336594912,3.727855361048901,"['NDUFA7', 'NDUFB7', 'NDUFS3', 'NDUFA1']",0.8571905693182404,0,0,4
36,Pathways Regulating Hippo Signaling WP4540,0.1569837534749693,1.8175205566097408,3.365344617756826,"['SMAD2', 'CDH2', 'PRKAR1B', 'GNAS', 'GNAI3']",0.8571905693182404,0,0,5
37,Synthesis and Degradation of Ketone Bodies WP311,0.16006108861232518,7.492217898832685,13.727239632244292,['OXCT1'],0.8571905693182404,0,0,1
38,Globo Sphingolipid Metabolism WP1424,0.16235874133588393,2.9996101364522416,5.453132066793772,"['ST8SIA1', 'B3GALT5']",0.8571905693182404,0,0,2
39,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.16235874133588393,2.9996101364522416,5.453132066793772,"['SMAD2', 'SHC1']",0.8571905693182404,0,0,2
40,IL-2 signaling pathway WP49,0.16499121489233504,2.251171875,4.056303419806719,"['SHC1', 'RPS6', 'JAK1']",0.8571905693182404,0,0,3
41,Integrated Cancer Pathway WP1971,0.16499121489233504,2.251171875,4.056303419806719,"['SMAD2', 'BACH1', 'JAK1']",0.8571905693182404,0,0,3
42,Thermogenesis WP4321,0.16681515180515205,1.6699410609037328,2.990645602690071,"['SMARCC2', 'RPS6KA2', 'RPS6', 'GNAS', 'ADCY8', 'MGLL']",0.8571905693182404,0,0,6
43,Myometrial relaxation and contraction pathways WP289,0.17235875782891286,1.5785826771653544,2.775428028845279,"['RGS5', 'PRKAR1B', 'GNG5', 'GNAS', 'ARRB2', 'ADCY8', 'DGKZ']",0.8571905693182404,0,0,7
44,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.1752919236980801,1.5165166658379328,2.640714351647223,"['VAV3', 'MAPK10', 'CDKL5', 'RAP1A', 'CDH2', 'SHC1', 'RPS6', 'NCK2']",0.8571905693182404,0,0,8
45,Immune response to tuberculosis WP4197,0.1777670924741523,2.8118908382066277,4.856925772802451,"['PIAS1', 'JAK1']",0.8571905693182404,0,0,2
46,Prostaglandin Synthesis and Regulation WP98,0.1777670924741523,2.8118908382066277,4.856925772802451,"['CBR1', 'EDNRA']",0.8571905693182404,0,0,2
47,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.17819161243145334,1.7331825037707391,2.989559279170326,"['SHC1', 'RPS6', 'GAB1', 'NF1', 'JAK1']",0.8571905693182404,0,0,5
48,VEGFA-VEGFR2 Signaling Pathway WP3888,0.18957140204431083,1.2713661958389006,2.114268677100359,"['SHC1', 'USP10', 'RPS6', 'GAB1', 'NFATC2', 'ARNT', 'RPL13A', 'PTPRJ', 'NAP1L1', 'ARRB2', 'RPL10A', 'HDAC9', 'DPM1', 'NR4A2', 'RAP1A', 'MYO1C', 'RPLP2', 'RICTOR', 'RPL26']",0.8571905693182404,0,0,19
49,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.1933874306000059,2.646256163284027,4.34795683078197,"['DYRK1A', 'NFATC2']",0.8571905693182404,0,0,2
50,Cannabinoid receptor signaling WP3869,0.1933874306000059,2.646256163284027,4.34795683078197,"['MAPK10', 'PRKAR1B']",0.8571905693182404,0,0,2
51,PKC-gamma calcium signaling pathway in ataxia WP4760,0.1933874306000059,2.646256163284027,4.34795683078197,"['CACNA1A', 'HOMER3']",0.8571905693182404,0,0,2
52,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.19590827072156772,5.618677042801556,9.159054531241583,['JAK1'],0.8571905693182404,0,0,1
53,Tgif disruption of Shh signaling WP3674,0.19590827072156772,5.618677042801556,9.159054531241583,['SMAD2'],0.8571905693182404,0,0,1
54,Vitamin D Metabolism WP1531,0.19590827072156772,5.618677042801556,9.159054531241583,['CYP27A1'],0.8571905693182404,0,0,1
55,Mitochondrial fatty acid synthesis pathway WP4317,0.19590827072156772,5.618677042801556,9.159054531241583,['MECR'],0.8571905693182404,0,0,1
56,SARS-CoV-2 and COVID-19 Pathway WP4846,0.19590827072156772,5.618677042801556,9.159054531241583,['CTSL'],0.8571905693182404,0,0,1
57,Common Pathways Underlying Drug Addiction WP2636,0.19737651287116645,2.045987215909091,3.319905077457896,"['RAP1A', 'GNAS', 'ADCY8']",0.8571905693182404,0,0,3
58,IL-6 signaling pathway WP364,0.19737651287116645,2.045987215909091,3.319905077457896,"['SHC1', 'GAB1', 'JAK1']",0.8571905693182404,0,0,3
59,Ebola Virus Pathway on Host WP4217,0.19895971296045062,1.5721661260108741,2.5385026295281534,"['CTSL', 'HLA-B', 'TYRO3', 'RAB9A', 'MFGE8', 'HAVCR2']",0.8571905693182404,0,0,6
60,TGF-beta Receptor Signaling WP560,0.20849550447811419,1.9856387867647058,3.1131595455104284,"['SMAD2', 'ZFYVE9', 'JAK1']",0.8571905693182404,0,0,3
61,Interleukin-11 Signaling Pathway WP2332,0.20849550447811419,1.9856387867647058,3.1131595455104284,"['RPS6', 'JAK1', 'PIAS1']",0.8571905693182404,0,0,3
62,Netrin-UNC5B signaling pathway WP4747,0.20849550447811419,1.9856387867647058,3.1131595455104284,"['PPP2R1B', 'DAPK1', 'RLF']",0.8571905693182404,0,0,3
63,Endothelin Pathways WP2197,0.20917373959096333,2.4990253411306043,3.9099502644954343,"['EDNRA', 'GNAS']",0.8571905693182404,0,0,2
64,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.20917373959096333,2.4990253411306043,3.9099502644954343,"['SMAD2', 'MFGE8']",0.8571905693182404,0,0,2
65,Type II interferon signaling (IFNG) WP619,0.22508353011391222,2.367292500256489,3.5303047204723996,"['HLA-B', 'JAK1']",0.8571905693182404,0,0,2
66,Wnt signaling in kidney disease WP4150,0.22508353011391222,2.367292500256489,3.5303047204723996,"['MAPK10', 'WNT7A']",0.8571905693182404,0,0,2
67,Genes targeted by miRNAs in adipocytes WP1992,0.23022839945734636,4.494552529182879,6.601074787477199,['PTBP2'],0.8571905693182404,0,0,1
68,Insulin signaling in adipocytes (diabetic condition) WP3635,0.23022839945734636,4.494552529182879,6.601074787477199,['RPS6'],0.8571905693182404,0,0,1
69,Insulin signaling in adipocytes (normal condition) WP3634,0.23022839945734636,4.494552529182879,6.601074787477199,['RPS6'],0.8571905693182404,0,0,1
70,LDLRAD4 and what we know about it WP4904,0.23022839945734636,4.494552529182879,6.601074787477199,['SMAD2'],0.8571905693182404,0,0,1
71,Peroxiredoxin 2 induced ovarian failure WP4873,0.23022839945734636,4.494552529182879,6.601074787477199,['MAPK10'],0.8571905693182404,0,0,1
72,"Phase I biotransformations, non P450 WP136",0.23022839945734636,4.494552529182879,6.601074787477199,['PON2'],0.8571905693182404,0,0,1
73,Pilocytic astrocytoma WP2253,0.23022839945734636,4.494552529182879,6.601074787477199,['NF1'],0.8571905693182404,0,0,1
74,Focal Adhesion WP306,0.23646334263171345,1.3868608708845396,1.9998007895279712,"['VAV3', 'MAPK10', 'RAP1A', 'PPP1R12A', 'SHC1', 'COL5A2', 'PARVA', 'DOCK1']",0.8571905693182404,0,0,8
75,Integrated breast cancer pathway WP1984,0.23896150369721625,1.4207810172377102,2.0337809829589526,"['SMAD2', 'FER', 'RAP1A', 'NF1', 'BACH1', 'PIAS1', 'JAK1']",0.8571905693182404,0,0,7
76,Mesodermal commitment pathway WP2857,0.24022828763650192,1.4688647817545057,2.0948444363875502,"['SMAD2', 'VAV3', 'WDHD1', 'ATP8B2', 'WDFY2', 'PIAS1']",0.8571905693182404,0,0,6
77,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.25417108680665546,1.7760074013157894,2.432681997377859,"['SMAD2', 'ZFYVE9', 'JAK1']",0.8571905693182404,0,0,3
78,"GPCRs, Class A Rhodopsin-like WP455",0.25417108680665546,1.7760074013157894,2.432681997377859,"['EDNRA', 'HRH1', 'GPR37']",0.8571905693182404,0,0,3
79,Oxidation by Cytochrome P450 WP43,0.2571199465903304,2.1414647730437206,2.9085644044733128,"['CYP27A1', 'CYP39A1']",0.8571905693182404,0,0,2
80,Type III interferon signaling WP2113,0.26308640353577645,3.745136186770428,5.000778370901824,['JAK1'],0.8571905693182404,0,0,1
81,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.26308640353577645,3.745136186770428,5.000778370901824,['JAK1'],0.8571905693182404,0,0,1
82,Ketogenesis and Ketolysis WP4742,0.26308640353577645,3.745136186770428,5.000778370901824,['OXCT1'],0.8571905693182404,0,0,1
83,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.26308640353577645,3.745136186770428,5.000778370901824,['CDO1'],0.8571905693182404,0,0,1
84,Nanoparticle triggered regulated necrosis WP2513,0.26308640353577645,3.745136186770428,5.000778370901824,['FTL'],0.8571905693182404,0,0,1
85,Prolactin Signaling Pathway WP2037,0.2718799005224915,1.55179161886767,2.021045416397249,"['SHC1', 'RPS6KA2', 'RPS6', 'JAK1']",0.8571905693182404,0,0,4
86,Oxysterols derived from cholesterol WP4545,0.2731773408376726,2.04394825447457,2.652296942518562,"['CYP39A1', 'CYP27A1']",0.8571905693182404,0,0,2
87,IL-4 signaling pathway WP395,0.27752142340320624,1.6869140625,2.1623828479345124,"['HRH1', 'SHC1', 'JAK1']",0.8571905693182404,0,0,3
88,NRF2 pathway WP2884,0.28005275505101834,1.442684766214178,1.836216396482104,"['CBR1', 'SLC39A9', 'SLC6A16', 'SLC39A12', 'FTL']",0.8571905693182404,0,0,5
89,BDNF-TrkB Signaling WP3676,0.28921937812061493,1.9549114331723028,2.425204056330448,"['SHC1', 'GAB1']",0.8571905693182404,0,0,2
90,Estrogen Receptor Pathway WP2881,0.29454445665281737,3.209838799332963,3.923467272552705,['ACOX1'],0.8571905693182404,0,0,1
91,Major receptors targeted by epinephrine and norepinephrine WP4589,0.29454445665281737,3.209838799332963,3.923467272552705,['ADCY8'],0.8571905693182404,0,0,1
92,Nuclear receptors WP170,0.30521818990674654,1.8732943469785575,2.223091568259275,"['NR4A2', 'NR2F1']",0.8571905693182404,0,0,2
93,IL17 signaling pathway WP2112,0.3211483046023279,1.798206627680312,2.042497051996153,"['IL17RB', 'JAK1']",0.8571905693182404,0,0,2
94,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.32466209371691557,2.8083657587548636,3.1593282082171896,['JAK1'],0.8571905693182404,0,0,1
95,Peptide GPCRs WP24,0.32466209371691557,2.8083657587548636,3.1593282082171896,['EDNRA'],0.8571905693182404,0,0,1
96,Ras signaling WP4223,0.32613917155965766,1.2703835407670816,1.4233772052502496,"['MAPK10', 'SYNGAP1', 'RAP1A', 'GNG5', 'SHC1', 'NF1', 'GAB1']",0.8571905693182404,0,0,7
97,Corticotropin-releasing hormone signaling pathway WP2355,0.33002096825660177,1.4055772994129159,1.5582217099497178,"['NR4A2', 'JUND', 'GNAS', 'ARRB2']",0.8571905693182404,0,0,4
98,Rett syndrome causing genes WP4312,0.33652705721235876,1.498828125,1.6323388262623022,"['SYNGAP1', 'CDKL5', 'TBL1XR1']",0.8571905693182404,0,0,3
99,Alpha 6 Beta 4 signaling pathway WP244,0.3369864945838702,1.7288948867896237,1.8805404496234728,"['SHC1', 'GAB1']",0.8571905693182404,0,0,2
100,Regulatory circuits of the STAT3 signaling pathway WP4538,0.3483395762043494,1.466117527173913,1.5461345290883242,"['MAPK10', 'RICTOR', 'JAK1']",0.8571905693182404,0,0,3
101,PDGFR-beta pathway WP3972,0.35271163160891056,1.6647173489278753,1.7348093798222224,"['SHC1', 'JAK1']",0.8571905693182404,0,0,2
102,Dopaminergic Neurogenesis WP2855,0.35349632277906384,2.4961089494163424,2.595659255829041,['NR4A2'],0.8571905693182404,0,0,1
103,Ganglio Sphingolipid Metabolism WP1423,0.35349632277906384,2.4961089494163424,2.595659255829041,['ST8SIA1'],0.8571905693182404,0,0,1
104,Hypertrophy Model WP516,0.35349632277906384,2.4961089494163424,2.595659255829041,['JUND'],0.8571905693182404,0,0,1
105,miR-509-3p alteration of YAP1/ECM axis WP3967,0.35349632277906384,2.4961089494163424,2.595659255829041,['EDNRA'],0.8571905693182404,0,0,1
106,Monoamine GPCRs WP58,0.35349632277906384,2.4961089494163424,2.595659255829041,['HRH1'],0.8571905693182404,0,0,1
107,Purine metabolism WP4792,0.35349632277906384,2.4961089494163424,2.595659255829041,['DGUOK'],0.8571905693182404,0,0,1
108,Aryl Hydrocarbon Receptor Netpath WP2586,0.36830455055617595,1.6051239209133945,1.6032701633583502,"['NF1', 'ARNT']",0.8571905693182404,0,0,2
109,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.36830455055617595,1.6051239209133945,1.6032701633583502,"['RPS6', 'JAK1']",0.8571905693182404,0,0,2
110,Tumor suppressor activity of SMARCB1 WP4204,0.36830455055617595,1.6051239209133945,1.6032701633583502,"['SMARCC2', 'EED']",0.8571905693182404,0,0,2
111,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.37188912649763417,1.40478515625,1.3895566054976054,"['CDH2', 'CTSL', 'PARVA']",0.8571905693182404,0,0,3
112,Cancer immunotherapy by PD-1 blockade WP4585,0.38110173192252184,2.2463035019455253,2.1669841140580672,['NFATC2'],0.8571905693182404,0,0,1
113,Type II diabetes mellitus WP1584,0.38110173192252184,2.2463035019455253,2.1669841140580672,['CACNA1A'],0.8571905693182404,0,0,1
114,Leptin Insulin Overlap WP3935,0.38110173192252184,2.2463035019455253,2.1669841140580672,['DGKZ'],0.8571905693182404,0,0,1
115,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.38174051184815616,1.2490196078431373,1.202823605381671,"['SMAD2', 'CDH2', 'SHC1', 'EED', 'WNT7A']",0.8571905693182404,0,0,5
116,Wnt signaling WP428,0.398496727241362,1.2662275019982911,1.1650002023224704,"['NFATC2', 'WNT7A', 'GPC4', 'CXXC4']",0.8571905693182404,0,0,4
117,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.399026126085622,1.4978557504873293,1.376122595094377,"['MAPK10', 'RPS6KA2']",0.8571905693182404,0,0,2
118,Genes related to primary cilium development (based on CRISPR) WP4536,0.40735321282639586,1.2084123972169514,1.0852445106170996,"['BBS2', 'CEP19', 'BBS9', 'TUBD1', 'TTBK2']",0.8571905693182404,0,0,5
119,Cysteine and methionine catabolism WP4504,0.4075305916362913,2.0419172267421293,1.8329051043702749,['CDO1'],0.8571905693182404,0,0,1
120,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.4075305916362913,2.0419172267421293,1.8329051043702749,['EXPH5'],0.8571905693182404,0,0,1
121,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.4075305916362913,2.0419172267421293,1.8329051043702749,['ACOX1'],0.8571905693182404,0,0,1
122,Canonical and non-canonical TGF-B signaling WP3874,0.4328329532604037,1.8715953307392996,1.5672803208085826,['SMAD2'],0.8571905693182404,0,0,1
123,IL-9 signaling pathway WP22,0.4328329532604037,1.8715953307392996,1.5672803208085826,['JAK1'],0.8571905693182404,0,0,1
124,miRNA targets in ECM and membrane receptors WP2911,0.4328329532604037,1.8715953307392996,1.5672803208085826,['COL5A2'],0.8571905693182404,0,0,1
125,Omega-3/Omega-6 FA synthesis WP4723,0.4328329532604037,1.8715953307392996,1.5672803208085826,['ACOX1'],0.8571905693182404,0,0,1
126,Phytochemical activity on NRF2 transcriptional activation WP3,0.4328329532604037,1.8715953307392996,1.5672803208085826,['MAF'],0.8571905693182404,0,0,1
127,ErbB signaling pathway WP673,0.4371761166760438,1.1982778864970647,0.9914780728085782,"['MAPK10', 'SHC1', 'NCK2', 'GAB1']",0.8571905693182404,0,0,4
128,ESC Pluripotency Pathways WP3931,0.4371761166760438,1.1982778864970647,0.9914780728085782,"['GAB1', 'WNT7A', 'FGF22', 'JAK1']",0.8571905693182404,0,0,4
129,MECP2 and Associated Rett Syndrome WP3584,0.44127286032998986,1.248046875,1.0210169942823628,"['RPS6', 'SP3', 'NF1']",0.8571905693182404,0,0,3
130,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.44373692965314104,1.3613326244905193,1.1061146029560842,"['JAK1', 'HAVCR2']",0.8571905693182404,0,0,2
131,Nonalcoholic fatty liver disease WP4396,0.44378104556617637,1.1329183932905185,0.920410068733303,"['NDUFA7', 'NDUFB7', 'UQCRB', 'NDUFS3', 'NDUFA1', 'COX7C']",0.8571905693182404,0,0,6
132,Neural Crest Differentiation WP2064,0.45256810978365947,1.2252485795454546,0.9713979132713867,"['CDH2', 'HDAC9', 'SOX5']",0.8571905693182404,0,0,3
133,SARS coronavirus and innate immunity WP4912,0.4570567429743037,1.7274768033522898,1.3525240448148481,['JAK1'],0.8571905693182404,0,0,1
134,PDGF Pathway WP2526,0.4582287132008858,1.3211787639032222,1.0310305281847663,"['SHC1', 'JAK1']",0.8571905693182404,0,0,2
135,T-cell receptor (TCR) signaling pathway WP69,0.46376815861141013,1.2032645089285714,0.9245529641396867,"['VAV3', 'SHC1', 'NFATC2']",0.8571905693182404,0,0,3
136,Head and Neck Squamous Cell Carcinoma WP4674,0.46376815861141013,1.2032645089285714,0.9245529641396867,"['RPS6', 'GAB1', 'RICTOR']",0.8571905693182404,0,0,3
137,TGF-beta Signaling Pathway WP366,0.4747038829249419,1.1119200155309648,0.8284516564148996,"['SMAD2', 'JUND', 'ZFYVE9', 'SHC1', 'PIAS1']",0.8571905693182404,0,0,5
138,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.4802478515835824,1.603946637020567,1.1764193939784655,['ACOX1'],0.8571905693182404,0,0,1
139,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.4802478515835824,1.603946637020567,1.1764193939784655,['EED'],0.8571905693182404,0,0,1
140,MAPK pathway in congenital thyroid cancer WP4928,0.4802478515835824,1.603946637020567,1.1764193939784655,['SHC1'],0.8571905693182404,0,0,1
141,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.4802478515835824,1.603946637020567,1.1764193939784655,['LPP'],0.8571905693182404,0,0,1
142,Mitochondrial complex III assembly WP4921,0.4802478515835824,1.603946637020567,1.1764193939784655,['UQCRB'],0.8571905693182404,0,0,1
143,Overview of interferons-mediated signaling pathway WP4558,0.4802478515835824,1.603946637020567,1.1764193939784655,['JAK1'],0.8571905693182404,0,0,1
144,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.486540803849119,1.2475633528265107,0.8987876910711239,"['CHP1', 'NFATC2']",0.8571905693182404,0,0,2
145,Endochondral Ossification with Skeletal Dysplasias WP4808,0.486540803849119,1.2475633528265107,0.8987876910711239,"['CHST11', 'SOX5']",0.8571905693182404,0,0,2
146,Endochondral Ossification WP474,0.486540803849119,1.2475633528265107,0.8987876910711239,"['CHST11', 'SOX5']",0.8571905693182404,0,0,2
147,IL-3 signaling pathway WP286,0.486540803849119,1.2475633528265107,0.8987876910711239,"['SHC1', 'JAK1']",0.8571905693182404,0,0,2
148,16p11.2 proximal deletion syndrome WP4949,0.4967395270777191,1.1417836334745763,0.7988939975270744,"['PPP4R1', 'ASPHD1', 'KCTD13']",0.8571905693182404,0,0,3
149,Splicing factor NOVA regulated synaptic proteins WP4148,0.5003471220033332,1.213740055845319,0.8404581582431511,"['CADM3', 'CDH2']",0.8571905693182404,0,0,2
150,ATM Signaling Network in Development and Disease  WP3878,0.5003471220033332,1.213740055845319,0.8404581582431511,"['RNF8', 'RNF40']",0.8571905693182404,0,0,2
151,Phosphodiesterases in neuronal function WP4222,0.5003471220033332,1.213740055845319,0.8404581582431511,"['ADCY8', 'PDE8A']",0.8571905693182404,0,0,2
152,Apoptosis Modulation by HSP70 WP384,0.502450221171422,1.496887159533074,1.0302456198993108,['MAPK10'],0.8571905693182404,0,0,1
153,Transcription co-factors SKI and SKIL protein partners WP4533,0.502450221171422,1.496887159533074,1.0302456198993108,['NF1'],0.8571905693182404,0,0,1
154,Microglia Pathogen Phagocytosis Pathway WP3937,0.502450221171422,1.496887159533074,1.0302456198993108,['VAV3'],0.8571905693182404,0,0,1
155,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.502450221171422,1.496887159533074,1.0302456198993108,['SOX5'],0.8571905693182404,0,0,1
156,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.5075031624812189,1.12265625,0.7614442247560685,"['RPS6', 'ADCY8', 'MGLL']",0.8571905693182404,0,0,3
157,Pathogenic Escherichia coli infection WP2272,0.5139126229407631,1.181696932389453,0.7866580375857346,"['TUBB3', 'NCK2']",0.8571905693182404,0,0,2
158,Fragile X Syndrome  WP4549,0.5235444984957253,1.0490196078431373,0.6788554685379263,"['SYNGAP1', 'KCND2', 'SHC1', 'NF1', 'GAB1']",0.8571905693182404,0,0,5
159,Angiogenesis WP1539,0.5237059274110977,1.4032101167315174,0.9076313268231849,['ARNT'],0.8571905693182404,0,0,1
160,Canonical and non-canonical Notch signaling WP3845,0.5237059274110977,1.4032101167315174,0.9076313268231849,['MAML2'],0.8571905693182404,0,0,1
161,Methionine De Novo and Salvage Pathway WP3580,0.5237059274110977,1.4032101167315174,0.9076313268231849,['AMD1'],0.8571905693182404,0,0,1
162,Monoamine Transport WP727,0.5237059274110977,1.4032101167315174,0.9076313268231849,['FBXO32'],0.8571905693182404,0,0,1
163,Purine metabolism and related disorders WP4224,0.5237059274110977,1.4032101167315174,0.9076313268231849,['DGUOK'],0.8571905693182404,0,0,1
164,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.5272326945275068,1.151297046033888,0.7369605310394524,"['SMAD2', 'ADCY8']",0.8571905693182404,0,0,2
165,Genotoxicity pathway WP4286,0.5272326945275068,1.151297046033888,0.7369605310394524,"['RPS27', 'BRMS1L']",0.8571905693182404,0,0,2
166,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.5272326945275068,1.151297046033888,0.7369605310394524,"['ATG10', 'FTL']",0.8571905693182404,0,0,2
167,PPAR signaling pathway WP3942,0.5272326945275068,1.151297046033888,0.7369605310394524,"['CYP27A1', 'ACOX1']",0.8571905693182404,0,0,2
168,Leptin signaling pathway WP2034,0.5390516482376819,1.0689174107142858,0.6605309832187317,"['SHC1', 'RPS6', 'JAK1']",0.8571905693182404,0,0,3
169,Wnt Signaling Pathway WP363,0.5403035542314222,1.1224171539961014,0.6909871174842895,"['NFATC2', 'ARRB2']",0.8571905693182404,0,0,2
170,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.5440552588223835,1.32055390249485,0.8038270482271239,['JAK1'],0.8571905693182404,0,0,1
171,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.5440552588223835,1.32055390249485,0.8038270482271239,['CBX5'],0.8571905693182404,0,0,1
172,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.5440552588223835,1.32055390249485,0.8038270482271239,['EED'],0.8571905693182404,0,0,1
173,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.5440552588223835,1.32055390249485,0.8038270482271239,['RPS6'],0.8571905693182404,0,0,1
174,Genes controlling nephrogenesis WP4823,0.5440552588223835,1.32055390249485,0.8038270482271239,['NCK2'],0.8571905693182404,0,0,1
175,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.5440552588223835,1.32055390249485,0.8038270482271239,['ZFX'],0.8571905693182404,0,0,1
176,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.5440552588223835,1.32055390249485,0.8038270482271239,['ATG10'],0.8571905693182404,0,0,1
177,miRNA regulation of p53 pathway in prostate cancer WP3982,0.5440552588223835,1.32055390249485,0.8038270482271239,['ZMAT3'],0.8571905693182404,0,0,1
178,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.5531221870576417,1.09494603717967,0.6484011464064143,"['VAV3', 'JUND']",0.8571905693182404,0,0,2
179,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.5531221870576417,1.09494603717967,0.6484011464064143,"['SYNGAP1', 'NF1']",0.8571905693182404,0,0,2
180,Synaptic Vesicle Pathway WP2267,0.5531221870576417,1.09494603717967,0.6484011464064143,"['CACNA1B', 'CACNA1A']",0.8571905693182404,0,0,2
181,DNA IR-double strand breaks and cellular response via ATM WP3959,0.5531221870576417,1.09494603717967,0.6484011464064143,"['RNF8', 'MCPH1']",0.8571905693182404,0,0,2
182,7-oxo-C and 7beta-HC pathways WP5064,0.5635367926033713,1.2470817120622568,0.7152296140519219,['CYP27A1'],0.8571905693182404,0,0,1
183,Signal Transduction of S1P Receptor WP26,0.5635367926033713,1.2470817120622568,0.7152296140519219,['GNAI3'],0.8571905693182404,0,0,1
184,TYROBP causal network in microglia WP3945,0.5635367926033713,1.2470817120622568,0.7152296140519219,['MAF'],0.8571905693182404,0,0,1
185,Vitamin D in inflammatory diseases WP4482,0.5635367926033713,1.2470817120622568,0.7152296140519219,['DUSP1'],0.8571905693182404,0,0,1
186,Glycerolipids and Glycerophospholipids WP4722,0.5635367926033713,1.2470817120622568,0.7152296140519219,['DGKZ'],0.8571905693182404,0,0,1
187,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5635367926033713,1.2470817120622568,0.7152296140519219,['RPS6'],0.8571905693182404,0,0,1
188,IL-7 signaling pathway WP205,0.5635367926033713,1.2470817120622568,0.7152296140519219,['JAK1'],0.8571905693182404,0,0,1
189,B Cell Receptor Signaling Pathway WP23,0.5694116699671837,1.0200639204545454,0.5744506382374788,"['SHC1', 'GAB1', 'NFATC2']",0.8571905693182404,0,0,3
190,Joubert Syndrome WP4656,0.5694116699671837,1.0200639204545454,0.5744506382374788,"['BBS2', 'CSPP1', 'BBS9']",0.8571905693182404,0,0,3
191,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.5779942026048607,1.0438369826374723,0.5722224991127149,"['SMAD2', 'NAP1L1']",0.8571905693182404,0,0,2
192,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.5779942026048607,1.0438369826374723,0.5722224991127149,"['WNT7A', 'CXXC4']",0.8571905693182404,0,0,2
193,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.5782641167140181,0.9752165337449619,0.534150052064766,"['TBC1D1', 'PPP2R1B', 'GNG5', 'RPS6', 'COL5A2', 'HIF3A', 'FGF22', 'JAK1']",0.8571905693182404,0,0,8
194,Wnt signaling pathway and pluripotency WP399,0.5792539132178026,1.0047516324626866,0.5486088195876628,"['MAPK10', 'PPP2R1B', 'WNT7A']",0.8571905693182404,0,0,3
195,Hippo-Merlin Signaling Dysregulation WP4541,0.5792539132178026,1.0047516324626866,0.5486088195876628,"['PPP1R12A', 'CDH2', 'PRKAR1B']",0.8571905693182404,0,0,3
196,Fatty Acid Biosynthesis WP357,0.5821874669282505,1.1813434364120419,0.6390628235803293,['MECR'],0.8571905693182404,0,0,1
197,Nanoparticle triggered autophagic cell death WP2509,0.5821874669282505,1.1813434364120419,0.6390628235803293,['ATG10'],0.8571905693182404,0,0,1
198,Cell migration and invasion through p75NTR WP4561,0.6000426507529047,1.1221789883268483,0.5731580148929687,['PARD3'],0.8571905693182404,0,0,1
199,EPO Receptor Signaling WP581,0.6000426507529047,1.1221789883268483,0.5731580148929687,['SHC1'],0.8571905693182404,0,0,1
200,Estrogen signaling pathway WP712,0.6000426507529047,1.1221789883268483,0.5731580148929687,['GNAS'],0.8571905693182404,0,0,1
201,Heart Development WP1591,0.6000426507529047,1.1221789883268483,0.5731580148929687,['NFATC2'],0.8571905693182404,0,0,1
202,NRF2-ARE regulation WP4357,0.6000426507529047,1.1221789883268483,0.5731580148929687,['MAF'],0.8571905693182404,0,0,1
203,Oxidative Stress WP408,0.6000426507529047,1.1221789883268483,0.5731580148929687,['MAPK10'],0.8571905693182404,0,0,1
204,SARS-CoV-2 mitochondrial interactions WP5038,0.6000426507529047,1.1221789883268483,0.5731580148929687,['CTSL'],0.8571905693182404,0,0,1
205,Cardiac Hypertrophic Response WP2795,0.6018378398236629,0.997270955165692,0.506381519462674,"['NFATC2', 'HDAC9']",0.8571905693182404,0,0,2
206,Pancreatic adenocarcinoma pathway WP4263,0.6079165720762861,0.9614397321428572,0.4785254985349298,"['SMAD2', 'MAPK10', 'JAK1']",0.8571905693182404,0,0,3
207,Ciliary landscape WP4352,0.613263600677097,0.9439219350150524,0.4615404639601543,"['BBS2', 'AFG3L2', 'TFAP2C', 'WDR26', 'RMND5A', 'TNKS1BP1', 'BBS9', 'CDR2']",0.8571905693182404,0,0,8
208,Kit receptor signaling pathway WP304,0.6133730825499094,0.9755063988473599,0.4768098814720205,"['SHC1', 'RPS6']",0.8571905693182404,0,0,2
209,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6133730825499094,0.9755063988473599,0.4768098814720205,"['SP3', 'JAK1']",0.8571905693182404,0,0,2
210,Ethanol effects on histone modifications WP3996,0.6171362101608067,1.0686492495831017,0.5158001430012777,['HDAC9'],0.8571905693182404,0,0,1
211,"GPCRs, Other WP117",0.6171362101608067,1.0686492495831017,0.5158001430012777,['EDNRA'],0.8571905693182404,0,0,1
212,Hematopoietic Stem Cell Differentiation WP2849,0.6171362101608067,1.0686492495831017,0.5158001430012777,['NFATC2'],0.8571905693182404,0,0,1
213,Lung fibrosis WP3624,0.6171362101608067,1.0686492495831017,0.5158001430012777,['ELMOD2'],0.8571905693182404,0,0,1
214,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.6171362101608067,1.0686492495831017,0.5158001430012777,['CARD8'],0.8571905693182404,0,0,1
215,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.6171362101608067,1.0686492495831017,0.5158001430012777,['RAP1A'],0.8571905693182404,0,0,1
216,Male infertility WP4673,0.6171772099091332,0.947815801056338,0.4574150375268818,"['PON2', 'MLH3', 'SOX5']",0.8571905693182404,0,0,3
217,AGE/RAGE pathway WP2324,0.6246510951860403,0.9546679938617229,0.44923051186581114,"['SMAD2', 'SHC1']",0.8617258218544569,0,0,2
218,Notch Signaling Pathway Netpath WP61,0.6356727871887707,0.9346978557504874,0.4234848040061242,"['MAML2', 'FBXW7']",0.8617258218544569,0,0,2
219,Circadian rhythm related genes WP3594,0.6357349811150443,0.918836387013822,0.41620853309088723,"['MAPK10', 'JUND', 'KCND2', 'DYRK1A', 'ARNT']",0.8617258218544569,0,0,5
220,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6464394580345292,0.9155428253172614,0.399429115273497,"['SHC1', 'NEFH']",0.8617258218544569,0,0,2
221,16p11.2 distal deletion syndrome WP4950,0.6491667857970241,0.9755540517678903,0.42150335294586555,['NFATC2'],0.8617258218544569,0,0,1
222,Glycerophospholipid Biosynthetic Pathway WP2533,0.6491667857970241,0.9755540517678903,0.42150335294586555,['LPIN2'],0.8617258218544569,0,0,1
223,Nanoparticle-mediated activation of receptor signaling WP2643,0.6491667857970241,0.9755540517678903,0.42150335294586555,['MAPK10'],0.8617258218544569,0,0,1
224,Neovascularisation processes WP4331,0.6491667857970241,0.9755540517678903,0.42150335294586555,['SMAD2'],0.8617258218544569,0,0,1
225,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.6491667857970241,0.9755540517678903,0.42150335294586555,['ARNT'],0.8617258218544569,0,0,1
226,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.6491667857970241,0.9755540517678903,0.42150335294586555,['SMAD2'],0.8617258218544569,0,0,1
227,DNA damage response (only ATM dependent) WP710,0.6612300455242602,0.8850740131578947,0.3661139395516353,"['MAPK10', 'SHC1', 'WNT7A']",0.8621288116827044,0,0,3
228,Glycosylation and related congenital defects WP4521,0.6641645803490698,0.9348249027237354,0.382553999625765,['DPM1'],0.8621288116827044,0,0,1
229,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.6641645803490698,0.9348249027237354,0.382553999625765,['RICTOR'],0.8621288116827044,0,0,1
230,Apoptosis WP254,0.6672146774619464,0.8794862974429538,0.35587835167078863,"['MAPK10', 'CRADD']",0.8621288116827044,0,0,2
231,MET in type 1 papillary renal cell carcinoma WP4205,0.6672146774619464,0.8794862974429538,0.35587835167078863,"['RAP1A', 'GAB1']",0.8621288116827044,0,0,2
232,Pathways affected in adenoid cystic carcinoma WP3651,0.6672146774619464,0.8794862974429538,0.35587835167078863,"['FBXW7', 'ATRX']",0.8621288116827044,0,0,2
233,Metapathway biotransformation Phase I and II WP702,0.6695867104069004,0.8735034496753247,0.3503575229186702,"['CYP27A1', 'CYP39A1', 'CHST11']",0.8621288116827044,0,0,3
234,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.677227473096036,0.8624981256560204,0.3361569719929374,"['WNT7A', 'CXXC4']",0.862528502208619,0,0,2
235,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6785224217374469,0.8973540856031128,0.3480277932952869,['ARRB2'],0.862528502208619,0,0,1
236,Oxidative Damage WP3941,0.6785224217374469,0.8973540856031128,0.3480277932952869,['MAPK10'],0.862528502208619,0,0,1
237,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.6922675656605302,0.8627656390302305,0.3173103128725499,['JAK1'],0.8703225285910742,0,0,1
238,Lipid Metabolism Pathway WP3965,0.6922675656605302,0.8627656390302305,0.3173103128725499,['PRKAR1B'],0.8703225285910742,0,0,1
239,Adipogenesis WP236,0.6937473888062395,0.84052734375,0.30733661922103106,"['ASIP', 'NR2F1', 'LPIN2']",0.8703225285910742,0,0,3
240,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.6962580228728593,0.8455488682937636,0.3061182547946569,"['MAPK10', 'SHC1', 'RPS6KA2', 'RICTOR']",0.8703225285910742,0,0,4
241,Regulation of Actin Cytoskeleton WP51,0.7030140437306576,0.837573385518591,0.29514277827765434,"['PPP1R12A', 'ARHGEF7', 'DOCK1', 'FGF22']",0.8708964311909903,0,0,4
242,Allograft Rejection WP2328,0.7054261092647022,0.830739299610895,0.2898891772123626,['HLA-B'],0.8708964311909903,0,0,1
243,Bladder cancer WP2828,0.7054261092647022,0.830739299610895,0.2898891772123626,['DAPK1'],0.8708964311909903,0,0,1
244,Insulin Signaling WP481,0.7127930381343133,0.8356745683347966,0.2829294664515815,"['MAPK10', 'MYO1C', 'SHC1', 'RPS6KA2', 'GAB1']",0.8718370648224736,0,0,5
245,Proteasome Degradation WP183,0.7148415395488238,0.8006126427179059,0.26876116780673337,"['PSMD6', 'HLA-B']",0.8718370648224736,0,0,2
246,Gastrin signaling pathway WP4659,0.7165524399483746,0.8099350527108434,0.2699544675526051,"['SHC1', 'RPS6', 'ARRB2']",0.8718370648224736,0,0,3
247,ATM Signaling Pathway WP2516,0.7180230401322988,0.8010005558643691,0.2653343346556241,['CRADD'],0.8718370648224736,0,0,1
248,Type 2 papillary renal cell carcinoma WP4241,0.7300822835023337,0.7733127599624312,0.24328267400180267,['ARNT'],0.8718370648224736,0,0,1
249,Hepatitis B infection WP4666,0.7351624904353251,0.799832261671792,0.24607937602501165,"['SMAD2', 'MAPK10', 'NFATC2', 'JAK1']",0.8718370648224736,0,0,4
250,Vitamin D-sensitive calcium signaling in depression WP4698,0.7416267472719064,0.7474708171206226,0.2234259027740485,['CYP27A1'],0.8718370648224736,0,0,1
251,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.7416267472719064,0.7474708171206226,0.2234259027740485,['SHC1'],0.8718370648224736,0,0,1
252,Mitochondrial CIV Assembly WP4922,0.7416267472719064,0.7474708171206226,0.2234259027740485,['COX7C'],0.8718370648224736,0,0,1
253,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7487094617123417,0.7469785575048733,0.21617878586128303,"['SMAD2', 'MAPK10']",0.8718370648224736,0,0,2
254,Amyotrophic lateral sclerosis (ALS) WP2447,0.7526783650651636,0.7232960963976403,0.20550091987535923,['NEFH'],0.8718370648224736,0,0,1
255,Disruption of postsynaptic signaling by CNV WP4875,0.7526783650651636,0.7232960963976403,0.20550091987535923,['SYNGAP1'],0.8718370648224736,0,0,1
256,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7526783650651636,0.7232960963976403,0.20550091987535923,['JAK1'],0.8718370648224736,0,0,1
257,MAPK Cascade WP422,0.7526783650651636,0.7232960963976403,0.20550091987535923,['MAPK10'],0.8718370648224736,0,0,1
258,p38 MAPK Signaling Pathway WP400,0.7526783650651636,0.7232960963976403,0.20550091987535923,['SHC1'],0.8718370648224736,0,0,1
259,Vitamin D Receptor Pathway WP2877,0.7566178544243717,0.734669095324833,0.20489698377693,"['NFATC2', 'TRAK1']",0.8718370648224736,0,0,2
260,DNA IR-damage and cellular response via ATR WP4016,0.7566178544243717,0.734669095324833,0.20489698377693,"['SMARCC2', 'MCPH1']",0.8718370648224736,0,0,2
261,Target Of Rapamycin (TOR) Signaling WP1471,0.7632581378910105,0.7006322957198443,0.1892821100572485,['RICTOR'],0.8718370648224736,0,0,1
262,Ferroptosis WP4313,0.7632581378910105,0.7006322957198443,0.1892821100572485,['FTL'],0.8718370648224736,0,0,1
263,Alzheimer's disease WP2059,0.7643104934943685,0.7227567125699553,0.19426339286289449,"['CHP1', 'CACNA1D']",0.8718370648224736,0,0,2
264,G13 Signaling Pathway WP524,0.7733861734647361,0.6793420587194906,0.1745751331161468,['MAPK10'],0.87553151712989,0,0,1
265,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.7733861734647361,0.6793420587194906,0.1745751331161468,['MAPK10'],0.87553151712989,0,0,1
266,mRNA Processing WP411,0.7810377907409458,0.7459882583170254,0.18435737829718327,"['PRPF6', 'PRPF40A', 'SNRPF', 'PTBP2']",0.880869688805578,0,0,4
267,Ciliopathies WP4803,0.7872444116081543,0.7556968733439322,0.18077517444057614,"['BBS2', 'CEP19', 'CSPP1', 'BBS9', 'TTBK2']",0.8845442827057914,0,0,5
268,Glioblastoma signaling pathways WP2261,0.7930037167766558,0.6787169945064682,0.1574130477656325,"['GAB1', 'NF1']",0.8863263020519432,0,0,2
269,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.794739250839909,0.7068873355263158,0.16240114790395008,"['PRKAR1B', 'SP3', 'HDAC9']",0.8863263020519432,0,0,3
270,Spinal Cord Injury WP2431,0.7996780953285133,0.6685287015216316,0.1494469258884448,"['CHST11', 'CD47']",0.8885312170316815,0,0,2
271,Pathways in clear cell renal cell carcinoma WP4018,0.80616114859757,0.6586400642128196,0.14191824178750156,"['PBRM1', 'ARNT']",0.8898394650514947,0,0,2
272,Glycogen Synthesis and Degradation WP500,0.8097539131968601,0.6056893469344832,0.127815526807756,['PPP2R1B'],0.8898394650514947,0,0,1
273,One-carbon metabolism and related pathways WP3940,0.8097539131968601,0.6056893469344832,0.127815526807756,['CDO1'],0.8898394650514947,0,0,1
274,Histone Modifications WP2369,0.8178961815472373,0.5896989555601065,0.11854120612269503,['EED'],0.8929852672387473,0,0,1
275,Osteoblast differentiation WP4787,0.818569828302185,0.6397103870788081,0.1280678273875356,"['MAPK10', 'WNT7A']",0.8929852672387473,0,0,2
276,Breast cancer pathway WP4262,0.8215772889823069,0.67125,0.13192026790718922,"['SHC1', 'WNT7A', 'FGF22']",0.8930187923720726,0,0,3
277,Modulators of TCR signaling and T cell activation WP5072,0.8256906161062829,0.5745285842562107,0.11004240845144443,['DGKZ'],0.8942497647360466,0,0,1
278,22q11.2 copy number variation syndrome WP4657,0.8302627701755353,0.621832358674464,0.11566892599135836,"['PRKN', 'CBX5']",0.8958624177476397,0,0,2
279,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.833152048505305,0.5601167315175097,0.10224321653055815,['CYP27A1'],0.8958624177476397,0,0,1
280,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.8402946790403142,0.5464078959855746,0.09507641657259966,['PPP1R12A'],0.9003157275431938,0,0,1
281,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8471321036283432,0.5333518621456365,0.08848234323163581,['MAPK10'],0.9044114985355977,0,0,1
282,IL-18 signaling pathway WP4754,0.8529705440291724,0.681013868962219,0.10830181556735062,"['SLC4A7', 'FBXW7', 'TSHZ1', 'ZDHHC7', 'KLC1']",0.90495831035803,0,0,5
283,Selenium Micronutrient Network WP15,0.8536773394377416,0.5209030856936024,0.08240789915883276,['SELENOI'],0.90495831035803,0,0,1
284,Regulation of toll-like receptor signaling pathway WP1449,0.8613720188376278,0.5736992052781527,0.08561243836826729,"['MAPK10', 'ZMYND11']",0.9099000198989026,0,0,2
285,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.8659405664317826,0.49766536964980546,0.07163345701619755,['MAPK10'],0.9111657641150157,0,0,1
286,7q11.23 copy number variation syndrome WP4932,0.8705239619513914,0.5592592592592592,0.0775468852535899,"['MYO1C', 'ATP5F1E']",0.9111657641150157,0,0,2
287,Translation Factors WP107,0.8716819143366983,0.4868042632380308,0.06685316962852836,['EIF4G3'],0.9111657641150157,0,0,1
288,Cell cycle WP179,0.8791178144824011,0.5455237008510436,0.07028328675231045,"['SMAD2', 'CDC27']",0.9157477234191679,0,0,2
289,p53 transcriptional gene network WP4963,0.8824387892445801,0.4664396887159533,0.05833567764008836,['ZMAT3'],0.9160264248213633,0,0,1
290,Acute viral myocarditis WP4298,0.8969100540108597,0.4388876173037308,0.04775083942267296,['JAK1'],0.927837986907786,0,0,1
291,Toll-like Receptor Signaling Pathway WP75,0.9134772576128368,0.4068270251149629,0.03681654366395548,['MAPK10'],0.9395262154033643,0,0,1
292,Melanoma WP4685,0.9171858069182452,0.3995275152862702,0.03453723695396159,['NF1'],0.9395262154033643,0,0,1
293,PI3K-Akt signaling pathway WP4172,0.9193126209992368,0.5928243637880685,0.04987374418923419,"['PPP2R1B', 'GNG5', 'RPS6', 'FGF22', 'JAK1']",0.9395262154033643,0,0,5
294,Endometrial cancer WP4155,0.9207356910952971,0.3924841286094614,0.03241222802908688,['CTNNA2'],0.9395262154033643,0,0,1
295,Apoptosis Modulation and Signaling WP1772,0.9304996768879791,0.3727626459143969,0.02685141674683699,['CRADD'],0.9462708578521821,0,0,1
296,DNA Repair Pathways Full Network WP4946,0.9358278083197602,0.4466276803118908,0.029622038198770746,"['RAP1A', 'REV3L']",0.9484741300538111,0,0,2
297,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9441782318844892,0.3439389404369949,0.01975596475812376,['HDAC9'],0.9537153857419084,0,0,1
298,Pyrimidine metabolism WP4022,0.9570926760847447,0.31470926727681264,0.013801591282549402,['UPRT'],0.9621413131025696,0,0,1
299,Senescence and Autophagy in Cancer WP615,0.9589341753922277,0.3103112840466926,0.013012235054177347,['ATG10'],0.9621413131025696,0,0,1
300,Androgen receptor signaling pathway WP138,0.9655442803824132,0.2938767151341388,0.01030429198720224,['PIAS1'],0.9655442803824132,0,0,1
